Pathological Diagnosis and Clinical Feature Analysis of Descending Duodenal Mucosal Adenocarcinoma: A Case Report

Overview

Journal World J Gastrointest Surg

Publisher Baishideng Publishing Group

Specialty Gastroenterology

Date 2024 Dec 30

PMID 39734469

Authors

Jin-Yuan Zhang

Liu-Sheng Wu

Jun Yan

Qiang Jiang

Xiao-Qiang Li

Affiliations

Soon will be listed here.

Abstract

Background: Mucosal adenocarcinoma of the descending duodenum is a very rare gastrointestinal tumor. Due to its low incidence, it has rarely been the focus of clinical and pathological studies. The clinical manifestations of these tumors are usually nonspecific, and they are easily misdiagnosed or missed. Pathological diagnosis is the gold standard for diagnosis, but due to the small number of cases, the relevant pathological characteristics and diagnostic criteria are not completely clear. The purpose of this study was to deepen the understanding of the diagnosis and treatment of this disease and to provide a clinical guidance.

Case Summary: A 61-year-old woman who was hospitalized with recurrent abdominal pain for more than 20 days. The patient developed epigastric pain with no obvious cause more than 20 days prior, mainly left epigastric pain and middle epigastric pain, and presented persistent dull pain without nausea or vomiting, fever or chills. The patient was treated at a local hospital, gastroscopy revealed a new lesion in the circum-intestinal cavity in the descending part of the duodenum, and pathological biopsy revealed mucous adenocarcinoma in the descending part of the duodenum. Currently, for further diagnosis and treatment, the patient is admitted to our hospital for surgical treatment for "malignant tumor of the duodenum" in the outpatient department.

Conclusion: Mucosal adenocarcinoma of the descending duodenum has a high misdiagnosis rate and missed diagnosis rate, clinical manifestations lack specificity, and pathological diagnosis is the main basis for diagnosis.

References

Liu W, Wang J, Ma L, Zhuang A, Xu J, He J . Which style of duodenojejunostomy is better after resection of distal duodenum. BMC Surg. 2022; 22(1):409. PMC: 9700921. DOI: 10.1186/s12893-022-01850-2. View

Fukusada S, Shimura T, Iwasaki H, Okuda Y, Katano T, Nishigaki R . Relationship between Immunophenotype and Clinicopathological Findings for Superficial Nonampullary Duodenal Epithelial Tumor. Digestion. 2021; 102(6):870-877. DOI: 10.1159/000514812. View

Beger H, Mayer B, Poch B . Resection of the duodenum causes long-term endocrine and exocrine dysfunction after Whipple procedure for benign tumors - Results of a systematic review and meta-analysis. HPB (Oxford). 2020; 22(6):809-820. DOI: 10.1016/j.hpb.2019.12.016. View

Beger H, Mayer B, Poch B . Duodenum-Preserving Pancreatic Head Resection for Benign and Premalignant Tumors-a Systematic Review and Meta-analysis of Surgery-Associated Morbidity. J Gastrointest Surg. 2023; 27(11):2611-2627. PMC: 10661729. DOI: 10.1007/s11605-023-05789-4. View

Wu L, Zheng Y, Ruan X, Wu D, Xu P, Liu J . Long-chain noncoding ribonucleic acids affect the survival and prognosis of patients with esophageal adenocarcinoma through the autophagy pathway: construction of a prognostic model. Anticancer Drugs. 2021; 33(1):e590-e603. PMC: 8670349. DOI: 10.1097/CAD.0000000000001189. View

Hayashi H, Miyamoto H, Nakagawa S, Matsuno K, Miyata T, Tsukamoto M . Distinct approaches (antecolic and retrocolic) according to tumor location in laparoscopic and endoscopic cooperative surgery for non-ampullary duodenum tumors. Surg Endosc. 2023; 37(9):6718-6726. DOI: 10.1007/s00464-023-10114-w. View

Iwamuro M, Tanaka T, Okada H . Review of lymphoma in the duodenum: An update of diagnosis and management. World J Gastroenterol. 2023; 29(12):1852-1862. PMC: 10080700. DOI: 10.3748/wjg.v29.i12.1852. View

Okano K, Oshima M, Suto H, Ando Y, Asano E, Kamada H . Ampullary carcinoma of the duodenum: current clinical issues and genomic overview. Surg Today. 2021; 52(2):189-197. DOI: 10.1007/s00595-021-02270-0. View

Wu L, Zhong Y, Yu X, Wu D, Xu P, Lv L . Selective poly adenylation predicts the efficacy of immunotherapy in patients with lung adenocarcinoma by multiple omics research. Anticancer Drugs. 2022; 33(9):943-959. PMC: 9481295. DOI: 10.1097/CAD.0000000000001319. View

10.

Chen Y, Zhang H, Zhou Q, Lu L, Lin J . Metastases to duodenum in cervical squamous cell carcinoma: A case report and review of the literature. Medicine (Baltimore). 2022; 101(2):e28526. PMC: 8757997. DOI: 10.1097/MD.0000000000028526. View

11.

Zeng Y, Yao H, Jiang X, Tang X, Wang X . GLI1-altered Mesenchymal Tumor Involving the Duodenum: Case Report and Literature Review. Int J Surg Pathol. 2023; 31(8):1538-1547. DOI: 10.1177/10668969231157782. View

12.

Wu L, Li X, Qian X, Wang S, Liu J, Yan J . Lipid Nanoparticle (LNP) Delivery Carrier-Assisted Targeted Controlled Release mRNA Vaccines in Tumor Immunity. Vaccines (Basel). 2024; 12(2). PMC: 10891594. DOI: 10.3390/vaccines12020186. View

13.

Boggi U . Laparoscopic duodenum-preserving total pancreatic head resection for pancreatic tumors: the difficult balance among overtreatment, ideal treatment, and undertreatment. Langenbecks Arch Surg. 2022; 407(8):3859-3861. DOI: 10.1007/s00423-022-02512-w. View

14.

Portale G, Mazzeo A, Zuin M, Spolverato Y, Cipollari C, Fiscon V . Fully Laparoscopic Pancreas-Preserving Resection of the Third and Fourth Portion of the Duodenum for Adenocarcinomas and Gastrointestinal Stromal Tumors: Technical Report on a Case Series. J Laparoendosc Adv Surg Tech A. 2021; 32(5):466-470. DOI: 10.1089/lap.2021.0480. View

15.

Abbass R, Rigaux J, Al-Kawas F . Nonampullary duodenal polyps: characteristics and endoscopic management. Gastrointest Endosc. 2010; 71(4):754-9. DOI: 10.1016/j.gie.2009.11.043. View

16.

Nakayama A, Kato M, Masunaga T, Kubosawa Y, Hayashi Y, Mizutani M . Differential diagnosis of superficial duodenal epithelial tumor and non-neoplastic lesion in duodenum by magnified endoscopic examination with image-enhanced endoscopy. J Gastroenterol. 2022; 57(3):164-173. DOI: 10.1007/s00535-021-01844-6. View

17.

Wu L, Chen X, Zeng Q, Lai Z, Fan Z, Ruan X . NR5A2 gene affects the overall survival of LUAD patients by regulating the activity of CSCs through SNP pathway by OCLR algorithm and immune score. Heliyon. 2024; 10(7):e28282. PMC: 11004709. DOI: 10.1016/j.heliyon.2024.e28282. View

18.

Del Toro C, Cabrera-Aguirre A, Casillas J, Ivanovic A, Scortegagna E, Estanga I . Imaging spectrum of non-neoplastic and neoplastic conditions of the duodenum: a pictorial review. Abdom Radiol (NY). 2023; 48(7):2237-2257. DOI: 10.1007/s00261-023-03909-x. View

19.

Wu L, Zhong Y, Wu D, Xu P, Ruan X, Yan J . Immunomodulatory Factor TIM3 of Cytolytic Active Genes Affected the Survival and Prognosis of Lung Adenocarcinoma Patients by Multi-Omics Analysis. Biomedicines. 2022; 10(9). PMC: 9496572. DOI: 10.3390/biomedicines10092248. View

20.

Milione M, Parente P, Grillo F, Zamboni G, Mastracci L, Capella C . Neuroendocrine neoplasms of the duodenum, ampullary region, jejunum and ileum. Pathologica. 2021; 113(1):12-18. PMC: 8138699. DOI: 10.32074/1591-951X-228. View